ReviewHuman vaccines & immunotherapeutics2019
Measles vaccination in an increasingly immunized and developed world.
Review in Human vaccines & immunotherapeutics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed.
- Measles-mumps-rubella-vaccination at 6 months of age induces measles-specific T cell responses: a randomized controlled trial.Frontiers in immunology · 2025Trial
- Measles challenges: global resurgence and factors affecting eradication.Italian journal of pediatrics · 2026Review
- A Nationwide Seroprevalence Study for Measles in Individuals of Fertile Age in Romania.Antibodies (Basel, Switzerland) · 2025Article
- Ongoing measles outbreak in Romania: Clinical investigation and molecular epidemiology performed on whole genome sequences.PloS one · 2025Observational
- Global and Regional Burden of Vaccine-Associated Erythema Multiforme and Their Related Vaccines, 1967-2023: An In-Depth Analysis of the World Health Organization Pharmacovigilance Database.Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2025Article
- The Epidemiology and Diagnosis of Measles—Special Aspects Relating to Low Incidence.Deutsches Arzteblatt international · 2024Review
- Determinants of second-dose measles vaccination dropout in Ethiopia: A community-based matched case-control study.Heliyon · 2024Article
- Pervasive Parental Hesitancy and Resistance towards Measles Rubella Vaccination in Jordan.Vaccines · 2023Article
- Understanding the challenges to COVID-19 vaccines and treatment options, herd immunity and probability of reinfection.Journal of Taibah University Medical Sciences · 2023Review
- Measles Serostatus in Mothers and Their Newborns in Antioquia, Colombia: Implications for Measles Elimination.The American journal of tropical medicine and hygiene · 2023Article
- Prevalence and management of rubella susceptibility in healthcare workers in Italy: A systematic review and meta-analysis.Vaccine: X · 2022Article
- Measles seroprevalence in persons over one year of age in Chandigarh, India.Human vaccines & immunotherapeutics · 2022Article
- Seroprevalence of Varicella-Zoster Virus and Measles among Healthcare Workers in a Tertiary Medical Center in Korea.Vaccines · 2022Article
- Hijab or Niqab Interacts with Facemasks Usage at Healthcare Settings in Kabul, Afghanistan: A Multi-Center Observational Study.Healthcare (Basel, Switzerland) · 2022Article
- Cross-National Comparison of Religion as a Predictor of COVID-19 Vaccination Rates.Journal of religion and health · 2022Article
- Effect of measles prevalence and vaccination coverage on other disease burden: evidence of measles immune amnesia in 46 African countries.Human vaccines & immunotherapeutics · 2021Article
- Review of the measles epidemic in children from Central Eastern Europe in the third millennium.Experimental and therapeutic medicine · 2021Article
- Socio-demographic correlates of first dose of measles (MCV1) vaccination coverage in India.BMC public health · 2020Article
- Vaccine hesitancy and the resurgence of vaccine preventable diseases: the way forward for Malaysia, a Southeast Asian country.Human vaccines & immunotherapeutics · 2020Article
- Reviewing Solutions of Scale for Canine Rabies Elimination in India.Tropical medicine and infectious disease · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Increased measles immunization has led to a significant decline in measles incidence and mortality. During 2016 it is estimated that fewer than 100,000 died from measles for the first time in recorded history. In highly immunized countries measles epidemiology has changed. Threats to national elimination goals and public health include aging cohorts of naïve people that exist from imperfect vaccination rates during the early years of immunization programs. This may be complemented by some loss of immunity in vaccinated populations. While childhood immunization must remain a focus for control efforts, due to higher mortality in the very young, these naïve adolescents and adults also accumulate as they age and add to the pool of susceptible people, perhaps beyond the view of those that are focused on childhood immunization. Here, features of measles epidemiology and control in highly immunized populations are reviewed, providing global data where necessary, to highlight why countries with high immunization coverage are still threatened by measles outbreaks and how changing dynamics may alter disease control.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.